跳至主要内容
临床试验/NCT06502353
NCT06502353招募中不适用

A Pilot Study to Investigate the Use of the Plexaa Preconditioning Device (BLOOM43) for Gender Affirming Mastectomy - a Prospective Cohort Study

Plexaa Ltd2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2025年8月20日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
Plexaa Ltd
入组人数
15
试验地点
2
主要终点
Participant experience

研究概览

简要总结

The goal of this clinical trial is to evaluate the use of the Plexaa preconditioning device (BLOOM43) in transgender and non-binary patients undergoing gender affirming mastectomy. This study aims to understand a participant's experience of the device, including its usability and acceptability.

Participants will use the device to precondition their right breast the evening before undergoing surgery (gender affirming mastectomy).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Prevention
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • All transgender or non-binary patients over the age of 18 years (no maximum age limit)
  • Patients undergoing peri-areolar mastectomy or double incision mastectomy with a free nipple graft for gender affirmation

排除标准

  • Patients undergoing surgery for breast cancer
  • Delayed (two-stage) breast reconstruction patients
  • Patients undergoing simple mastectomy or wide local excision of a breast tumour
  • Presence of open breast skin wounds, or infected or inflamed breast skin
  • Presence of a cardiac pacemaker, defibrillator or any other implantable electronic device

结局指标

主要结局

Participant experience

时间窗: 30 days

Participants' experience of the device will be evaluated with the use of a questionnaire. Most of the questions will consist of multiple-choice components with a five-point scale and there will also be a section for further comments from participants.

次要结局

  • Compliance(1 day)
  • Nipple necrosis/nipple graft loss(30 days)

研究者

发起方
Plexaa Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Plexaa For Preconditioning: Gender Affirming... | 临床试验